Dr. Ruff on Aflibercept in Elderly Patients With CRC

Paul Ruff, MD
Published: Wednesday, Oct 09, 2013

Paul Ruff, MD, director of Medical Oncology at the University of Witwatersrand, Johannesburg, South Africa, discusses treating elderly patients with colorectal cancer with aflibercept.

Ruff says physicians can use aflibercept to treat elderly patients with colorectal cancer as long as they are careful. Some side effects, such as dehydration, seem to be more severe in patients with colorectal cancer who are over the age of 65, Ruff says.

Ruff believes that most oncologists are aware of how to manage side effects from chemotherapy and anti-angiogenic agents. With good care management and proper awareness of its side effects, aflibercept can be used as a useful agent in the management of advanced colorectal cancer.

Paul Ruff, MD, director of Medical Oncology at the University of Witwatersrand, Johannesburg, South Africa, discusses treating elderly patients with colorectal cancer with aflibercept.

Ruff says physicians can use aflibercept to treat elderly patients with colorectal cancer as long as they are careful. Some side effects, such as dehydration, seem to be more severe in patients with colorectal cancer who are over the age of 65, Ruff says.

Ruff believes that most oncologists are aware of how to manage side effects from chemotherapy and anti-angiogenic agents. With good care management and proper awareness of its side effects, aflibercept can be used as a useful agent in the management of advanced colorectal cancer.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 18th Annual International Lung Cancer Congress®Oct 31, 20181.5
Provider and Caregiver Connection™: Addressing Patient Concerns While Managing Chemotherapy Induced Nausea and VomitingOct 31, 20182.0
Publication Bottom Border
Border Publication
x